Market closed
Cencora/$COR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Cencora
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Ticker
$COR
Sector
Trading on
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
44,000
Website
Cencora Metrics
BasicAdvanced
$44B
Market cap
30.05
P/E ratio
$7.53
EPS
0.46
Beta
$2.08
Dividend rate
0.97%
Dividend yield
Price and volume
Market cap
$44B
Beta
0.46
52-week high
$249.83
52-week low
$199.75
Average daily volume
1.2M
Dividend rate
$2.08
Financial strength
Current ratio
0.879
Quick ratio
0.498
Long term debt to equity
484.497
Total debt to equity
557.753
Dividend payout ratio (TTM)
27.58%
Interest coverage (TTM)
20.45%
Management effectiveness
Return on assets (TTM)
2.93%
Return on equity (TTM)
209.12%
Valuation
Price to earnings (TTM)
30.049
Price to revenue (TTM)
0.153
Price to book
56.45
Price to tangible book (TTM)
-3.54
Price to free cash flow (TTM)
14.984
Dividend yield (TTM)
0.92%
Forward dividend yield
0.97%
Growth
Revenue change (TTM)
12.12%
Earnings per share change (TTM)
-11.72%
3-year revenue growth (CAGR)
11.16%
3-year earnings per share growth (CAGR)
0.63%
3-year dividend per share growth (CAGR)
5.04%
What the Analysts think about Cencora
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Cencora stock.
Cencora Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Cencora Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Cencora News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Cencora stock?
Cencora (COR) has a market cap of $44B as of December 21, 2024.
What is the P/E ratio for Cencora stock?
The price to earnings (P/E) ratio for Cencora (COR) stock is 30.05 as of December 21, 2024.
Does Cencora stock pay dividends?
Yes, the Cencora (COR) stock pays dividends to shareholders. As of December 21, 2024, the dividend rate is $2.08 and the yield is 0.97%. Cencora has a payout ratio of 27.58% on a trailing twelve-month basis.
When is the next Cencora dividend payment date?
The next Cencora (COR) dividend payment date is unconfirmed.
What is the beta indicator for Cencora?
Cencora (COR) has a beta rating of 0.46. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.